HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   Clinical Trials (https://her2support.org/vbulletin/forumdisplay.php?f=29)
-   -   Medscape: Absolute Benefits of Medical Therapies in Phase III Clinical Trials (https://her2support.org/vbulletin/showthread.php?t=46492)

gdpawel 08-24-2010 06:22 PM

Medscape: Absolute Benefits of Medical Therapies in Phase III Clinical Trials
 
In randomized clinical trials of breast and colorectal cancer, new effective adjuvant treatments show decreasing absolute benefit, while new treatments of metastatic disease show unchanging levels of benefit at rapidly escalating costs.

The current research and treatment model makes no difference in outcomes, but adds a lot of profit to researchers, oncologists and pharmaceuticals. How about targeting "individuals" with "individualized" therapy?

From Annals of Oncology

http://www.medscape.com/viewarticle/...?src=emailthis

gdpawel 08-28-2010 10:26 AM

Cancer Clinical Trials are in a State of Crisis
 
Not good news. And improved treatments will be delayed and patient lives will be lost unless the efficiency and effectiveness of the clinical trials system improves, according to a new report from the Institute of Medicine (IOM), which was commission by the National Cancer Institute to review its Clinical Trials Cooperative Group (CTCG).

At issue are concerns the CTCG program can’t conduct timely, large-scale, innovative trials needed to improve patient care. The average time required to design, approve and activate a trial is two years, and only about half of all trials undertaken are completed. Meanwhile, funding since 2002 had dropped 20 percent, while knowledge about predictive biomarkers and molecular changes has grown.

To remedy the problem, the IOM says the CTCG needs to better respond to emerging scientific knowledge; involve broad cooperation of stakeholders; and leverage evolving technologies to provide high-quality research that can change practices.

Four recommended goals:

- Improving speed and efficiency of the design, launch, and conduct of trials;
- Incorporate innovative science and trial design into cancer trials;
- Improving prioritization, selection, support, and completion of clinical trials;
- Provide incentives to patients and physicians to participate.

http://books.nap.edu/openbook.php?re...=12879&page=R1


All times are GMT -7. The time now is 02:29 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021